Repurposed drugs as histone deacetylase 8 inhibitors: Implications in cancer and neuropathological conditions

Histone deacetylase 8 (HDAC8) is a member of class I histone deacetylases (HDACs) that catalyzes the deacetylation of both histone and non-histone proteins. Dysregulation and overexpression of HDAC8 are implicated in the development of various complex diseases, including cancer and neurodegenerative...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Mohammed Alrouji, Kumar Venkatesan, Mohammed S. Alshammari, Fahad A. Alhumaydhi, Sheeba Shafi, Sharaf E. Sharaf, Moyad Shahwan, Anas Shamsi
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Frontiers Media S.A. 2024-11-01
Loạt:Frontiers in Pharmacology
Những chủ đề:
Truy cập trực tuyến:https://www.frontiersin.org/articles/10.3389/fphar.2024.1488585/full